Efficacy and safety of a single intracavernous injection of autologous adipose-derived stem cells for post radical prostatectomy erectile dysfunctio
Not Applicable
- Conditions
- Erectile Dysfunction
- Registration Number
- JPRN-UMIN000050898
- Lead Sponsor
- Al Zahraa Hospital
- Brief Summary
Following ADSCs administration, the EF was improved in all patients of the treatment group. One month after therapy, all of the patients in the treatment group had an increase in their IEF-5 score. At 6 and 12 months, in this group, the degree of ED was moderate in 3 patients and mild in 4 patients. In the control group, for patients treated only with PDE5i, the ED remains severe all the time No significant side effects were reported by the patients after ADSCs injections
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
Impotent males before RP
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erectile function (EF) was tested using the IIEF-5 score after intracorporal injection of ADSCs
- Secondary Outcome Measures
Name Time Method Assess safety of ADSC therapy